NEW YORK, May 31 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company will host a conference call on June 7 at 8:00 am (ET) to review data presented at the 42nd Annual Meeting of the American Society of Clinical Oncology (ASCO), being held from June 2-6 in Atlanta, GA. Company executives will provide an overview of data presented at the meeting on the oncology portfolio and address inquiries from investors and analysts.
Investors and the general public are invited to listen to a live webcast of the call at www.bms.com/ir or by dialing 913-643-4199. A replay of the call will be available beginning at 12:00 p.m. (ET) on June 7 through 8:00 p.m. (ET) on June 21. The replay can be accessed at www.bms.com/ir or by dialing 402-280-9013 (access code 4363763).
Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.
Bristol-Myers Squibb
CONTACT: Media Communications, Tony Plohoros, +1-212-546-4379,tony.plohoros@bms.com, or Jeff Macdonald, +1-212-546-4824,jeffrey.macdonald@bms.com, or Investor Relations, John Elicker,+1-212-546-3775, john.elicker@bms.com, or Blaine Davis, +1-212-546-4631,blaine.davis@bms.com, all for Bristol-Myers Squibb
